Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
RX-10100
DRUG
2 trials
Sponsors
Rexahn Pharmaceuticals, Inc.
Conditions
Major Depressive Disorder
Major Depressive Disorder (MDD)
Phase 2
Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)
Completed
NCT00839176
Rexahn Pharmaceuticals, Inc.
Major Depressive Disorder (MDD)
Start: 2009-01-31
End: 2009-10-31
Updated: 2013-11-19
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
Completed
NCT01273376
Rexahn Pharmaceuticals, Inc.
Major Depressive Disorder
Start: 2010-12-31
End: 2011-10-31
Updated: 2013-11-19